Zydus Lifesciences informs about press release

19 Dec 2024 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated December 19, 2024, titled ‘Zydus receives final approval from USFDA for Lidocaine and Prilocaine Cream USP, 2.5%/2.5%.’

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

908.95 4.10 (0.45%)
16-Feb-2026 11:08 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1700.10
Dr. Reddys Lab 1265.75
Cipla 1345.65
Zydus Lifesciences 908.95
Lupin 2221.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×